Skip to main content
. 2011 Aug 6;1(1):e000130. doi: 10.1136/bmjopen-2011-000130

Table 2.

Acute/subacute hospital-treated somatic disease incidents: crude incidence rate ratios and treatment contact rate ratios of inpatient days and outpatient hospital contacts

IRR/TCRR (95% CI) p Value
Before versus during OMT, during OMT as reference (incidence rate=1)
All incidents 1.6 (1.3 to 1.9) <0.001
  Drug-related* 4.2 (2.9 to 6.2) <0.001
   Overdoses 2.8 (1.6 to 5.0) <0.001
   Injecting-related 5.9 (3.1 to 11.4) <0.001
   Other 5.7 (2.8 to 11.9) <0.001
  Non-drug-related 0.7 (0.6 to 1.0) 0.02
  Injuries 1.2 (0.9 to 1.5) 0.23
Inpatient days
  Drug-related 6.3 (3.4 to 11.8) <0.001
  Non-drug-related 0.5 (0.3 to 1.0) 0.04
  Injuries 2.1 (0.7 to 5.7) 0.17
  All 1.7 (1.1 to 2.4) 0.01
Outpatient contacts
  Drug-related 4.8 (2.7 to 8.3) <0.001
  Non-drug-related 0.7 (0.4 to 1.2) 0.18
  Injuries 1.1 (0.7 to 1.6) 0.78
  All 1.4 (1.0 to 1.8) 0.04
After versus during OMT, during OMT as reference (incidence rate=1)
All incidents 2.8 (2.1 to 3.9) <0.001
  Drug-related 11.1 (6.6 to 18.5) <0.001
   Overdoses 5.8 (2.7 to 12.3) <0.001
   Injecting-related 12.6 (4.3 to 36.8) <0.001
   Other 16.7 (6.5 to 42.7) <0.001
  Non-drug-related 1.4 (0.9 to 2.2) 0.15
  Injuries 0.8 (0.3 to 1.8) 0.57
 Inpatient days
  Drug-related 25.2 (13.1 to 48.7) <0.001
  Non-drug-related 1.1 (0.5 to 2.3) 0.78
  Injuries 4.6 (0.8 to 28.5) 0.98
  All 5.9 (3.6 to 9.6) <0.001
Outpatient contacts
  Drug-related 10.6 (4.7 to 25.9) <0.001
  Non-drug-related 1.6 (0.7 to 3.7) 0.26
  Injuries 1.1 (0.4 to 3.1) 0.87
  All 2.0 (1.1 to 3.8) 0.03

The incidence rate ratios indicate the statistical significance of the changes in incidence rates demonstrated in table 1, estimated by Poisson regression (generalised estimating equations). Patient-years at risk: 1000 before, 813 during and 91 after OMT. Number of incidents: 605 before, 310 during and 106 after OMT.

IRR, incidence rate ratios; OMT, opioid maintenance treatment; TCRR, treatment contact rate ratios.

*

Subgroups in italic.